Showing 3791-3800 of 4063 results for "".
- New Chair, Members Named to Eversight Board of Directorshttps://modernod.com/news/new-chair-members-named-to-eversight-board-of-directors/2477217/Eversight announced that two new members and a new chair have been named to its Board of Directors, effective Jan. 1, 2020. Joining the Eversight Board of Directors are Carolyn Welsh, Vice President & Chief Clinical Officer, NJ Sharing Network; and Mahmoud N. Ghazzi, MD, PhD, MPH, an e
- Aura Biosciences Appoints George Golumbeski, PhD, as Chairman of the Board of Directorshttps://modernod.com/news/aura-biosciences-appoints-george-golumbeski-phd-as-chairman-of-the-board-of-directors/2477212/Aura Biosciences announced the appointment of George Golumbeski, PhD, as Chairman of its Board of Directors. Dr. Golumbeski is a biopharmaceutical business leader with over 25 years of experience in the biotechnology industry. “George’s extensive experience will be invaluable to Aura as we
- EnChroma Introduces Line of Lenses for Low Vision and Age-Related Eye Conditionshttps://modernod.com/news/enchroma-introduces-line-of-lenses-for-low-vision-and-age-related-eye-conditions/2477199/EnChroma unveiled the “EnChroma Lx Series for Low Vision and Age-Related Eye Conditions,” a product line to address a rapidly growing category of visual challenges worldwide. The new line will be showcased at the Opti Munich 2020 International Trade Show for Optics and Design t
- Novartis Receives Permanent J-code for Beovuhttps://modernod.com/news/novartis-receives-permanent-j-code-for-beovu/2477192/Novartis announced that it has received a permanent J-code for Beovu (brolucizumab-dbll) injection, effective January 1, 2020. With the permanent J-code, retina specialists may now receive more timely reimbursement for Beovu injections, facilitating access for appropriate patients to this
- Allergan Foundation Giving Reaches $95 Million Since Inceptionhttps://modernod.com/news/allergan-foundation-giving-reaches-95-million-since-inception/2477188/Allergan announced that The Allergan Foundation has awarded a total of $10 million in charitable grants in 2019. The grants were donated to more than 400 organizations in 32 states as part of The Allergan Foundation’s commitment to providing a lasting and posit
- Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathyhttps://modernod.com/news/aldeyra-therapeutics-announces-first-patient-enrolled-in-the-phase-3-guard-trial-for-prevention-of-proliferative-vitreoretinopathy/2477182/Aldeyra Therapeutics announced enrollment of the first patient into the phase 3 GUARD Trial of ADX-2191 for the prevention of proliferative vitreoretinopathy (PVR). PVR is a serious, sight-threatening retinal disease with no approved treatment. “Initiation of patient enrollment in the GUAR
- SEED Acquires Majority Stake in Sensimedhttps://modernod.com/news/seed-acquires-majority-stake-in-sensimed/2477166/Sensimed announced the closure of a transaction whereby the Japanese public company SEED has acquired a majority stake in Sensimed. The transaction closed on November 29 with SEED now owning over 90% of outstanding sh
- Staar Surgical Announces FDA IDE Clinical Study Approvalhttps://modernod.com/news/staar-surgical-announces-fda-ide-clinical-study-approval-2/2477164/Staar Surgical announced that the FDA, in a letter dated December 6, 2019, stated that it has determined that Staar has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia, and EVO/EVO+ VISIAN To
- Retina Rocks: Retina Image & Reference Library Now Available Onlinehttps://modernod.com/news/retina-rocks-retina-image-reference-library-now-available-online/2477152/Retina Rocks, a new online, collection of open-source retina teachings, is now available at retinarocks.org. The website includes 22,000 multimodal images and 3,700 annotated references that are organized alphabetically by topic into approximately 360 sections
- Korean Ophthalmologist Oh Jungwoo Performs “25 Sec LASEK” in Public for the First Timehttps://modernod.com/news/korean-ophthalmologist-oh-jungwoo-performs-25-sec-lasek-in-public-for-the-first-time/2477147/Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed a “25 sec LASEK” surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh’s surgery on a patient’s left eye with minimal corneal damage in 25 second